endothelin antagonists (ImmunoPharmaceutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameendothelin antagonists (ImmunoPharmaceutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonistsEndothelin receptor type B antagonists
TargetsEndothelin receptor type AEndothelin receptor type B
Therapy Area/IndicationsHypertensionCardiovascular DiseasesKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunoPharmaceutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunoPharmaceutics Inc
Active IndicationsN/A
Inactive IndicationsHypertensionCardiovascular DiseasesKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A